$2.20-$2.30 is a proven support zone here. There are no investors buying XXII in the recent run up, it was all trader driven. This is a De Ja Vu.
Fundamentally, nothing changed since we up-listed. Yes, we signed LOI with Polish manufacturer, and it is great. But revenues are still non-existent and MSA is still "coming".